ARTICLE

FindCenter AddIcon

World-First Clinical Trial Explores Safety and Efficacy of DMT for Major Depression

By Ruairi J. Mackenzie — 2020

The world’s first clinical trial testing the efficacy of the psychedelic compound N,N-dimethyltryptamine (DMT) has won approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA).

Read on www.technologynetworks.com

FindCenter Post-Image
15:59

The Science of Psilocybin and Its Use to Relieve Suffering

Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.

FindCenter AddIcon
FindCenter Post-Image
01:32:51

Dr. Robin Carhart-Harris: Can Psychedelics Cure Depression?

Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.

FindCenter AddIcon
FindCenter Post-Image
29:53

Dr Robin Carhart-Harris - A Unified Model of the Brain Action of Psychedelics

REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.

FindCenter AddIcon
FindCenter Post-Image
27:57

How Psychedelics Can Treat Depression - Robin Carhart Harris

The talk will review brain imaging work on the action of psychedelics on the brain and describe the results of a clinical trial assessing psilocybin as a treatment for depression. It will also review the broader societal impact of psychedelic drug-use and discuss its implications.

FindCenter AddIcon
FindCenter Post-Image
16:26

Psychedelics: Lifting the Veil | Robin Carhart-Harris | TEDxWarwick

Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment.

FindCenter AddIcon
FindCenter Post-Image
47:50

The Secret to Ending Mental Illness | Dr. Daniel Amen on Health Theory

Daniel Amen wants to see the end of mental illness, and he may very well achieve his goal.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Revolutionaries: LSD and the Birth of Hallucinogenic Research

How three Canadian scientists paved the way for generations of hallucinogenic medical research Psychedelic Revolutionaries recounts the history of hallucino­genic-drug research in Saskatchewan, Canada, and the roles played by Humphry Osmond, Abram Hoffer, and Duncan Blewett.

FindCenter AddIcon
FindCenter Post-Image

DMT: The Spirit Molecule: A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences

From 1990 to 1995 Dr. Rick Strassman conducted U.S. Government-approved and funded clinical research at the University of New Mexico in which he injected sixty volunteers with DMT, one of the most powerful psychedelics known.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Medicine: The Healing Powers of LSD, MDMA, Psilocybin, and Ayahuasca

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers...

FindCenter AddIcon
FindCenter Post-Image

The Noonday Demon: An Atlas of Depression

The Noonday Demon examines depression in personal, cultural, and scientific terms.

FindCenter AddIcon

EXPLORE TOPIC

DMT